Nu Skin Enterprises, Inc.
NUS
$8.20
-$0.18-2.15%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.73B | 1.78B | 1.84B | 1.90B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.68B | 1.73B | 1.78B | 1.84B | 1.90B |
| Cost of Revenue | 505.72M | 511.43M | 454.34M | 532.17M | 535.80M |
| Gross Profit | 1.17B | 1.22B | 1.32B | 1.31B | 1.37B |
| SG&A Expenses | 1.08B | 1.13B | 1.17B | 1.21B | 1.25B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.59B | 1.64B | 1.63B | 1.74B | 1.78B |
| Operating Income | 88.83M | 89.58M | 149.75M | 105.15M | 123.86M |
| Income Before Tax | -41.55M | -175.05M | -107.92M | -155.67M | 13.09M |
| Income Tax Expenses | -3.01M | -28.46M | -4.71M | -7.21M | 16.41M |
| Earnings from Continuing Operations | -38.55 | -146.59 | -103.21 | -148.46 | -3.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.55M | -146.59M | -103.21M | -148.46M | -3.31M |
| EBIT | 88.83M | 89.58M | 149.75M | 105.15M | 123.86M |
| EBITDA | 154.41M | 159.39M | 221.69M | 176.27M | 196.24M |
| EPS Basic | -0.78 | -2.95 | -2.08 | -2.98 | -0.07 |
| Normalized Basic EPS | 0.87 | 0.83 | 1.57 | 0.97 | 1.21 |
| EPS Diluted | -0.80 | -2.95 | -2.08 | -2.99 | -0.07 |
| Normalized Diluted EPS | 0.87 | 0.83 | 1.57 | 0.97 | 1.21 |
| Average Basic Shares Outstanding | 198.87M | 198.65M | 198.34M | 198.50M | 198.74M |
| Average Diluted Shares Outstanding | 199.46M | 198.67M | 198.44M | 198.56M | 199.04M |
| Dividend Per Share | 0.24 | 0.24 | 0.57 | 0.90 | 1.23 |
| Payout Ratio | -31.00% | -8.14% | -27.34% | -30.12% | -1,846.98% |